Stockreport

Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2017

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF INBRIJA™ (levodopa inhalation powder) NDA resubmitted in December 2017 AMPYRA 4Q 2017 Net Sales of $167 million; Full Year 2017 Net Sale [Read more]